476 results on '"Coulie, Pierre G."'
Search Results
2. Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice
3. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
4. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8
5. Human Tumor Antigens Recognized by T Lymphocytes
6. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells
7. An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order
8. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
9. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes
10. Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
11. A Monoclonal Cytolytic T-Lymphocyte Response Observed in a Melanoma Patient Vaccinated with a Tumor-Specific Antigenic Peptide Encoded by Gene MAGE-3
12. Direct Selection of a Human Antibody Fragment Directed against the Tumor T-Cell Epitope HLA-A1-MAGE-A1 from a Nonimmunized Phage-Fab Library
13. Rôles du récepteur PD-1 et du facteur de transcription EOMES dans l’homéostasie des lymphocytes T CD8+ hépatiques
14. Supplementary Data from Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
15. Supplementary Table 1 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
16. Data from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
17. Supplementary Figure 2 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
18. Supplementary Figure 1 from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
19. Supplementary Figure 4 from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
20. Supplementary Figure 1 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
21. Supplementary Table 2 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
22. Supplementary Figure 2 from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
23. Supplementary Table 1 from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
24. Supplementary Table 2 from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
25. Supplementary Figure 3 from Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
26. Abstract P4-07-16: B-IMMUNE final analysis: a phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers
27. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells
28. Melanoma Antigens Recognized by T Lymphocytes
29. Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
30. Monoclonal and Recombinant Antibodies with T Cell Receptor-Like Reactivity
31. Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4
32. Facts and Hopes in Cancer Antigens Recognized by T Cells
33. Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial
34. An essential role for γ-herpesvirus latency-associated nuclear antigen homolog in an acute lymphoproliferative disease of cattle
35. Management of inflammatory bowel disease in pregnancy
36. Pandemic chilblains: Are they SARS-CoV-2-related or not?
37. Characterization of Antigens Recognized by T Cells on Human Tumors
38. Pandemic chilblains: Are they SARS-CoV-2-related or not?
39. Preprocalcitonin Signal Peptide Generates a Cytotoxic T Lymphocyte-Defined Tumor Epitope Processed by a Proteasome-Independent Pathway
40. Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients
41. A Mutated Intron Sequence Codes for an Antigenic Peptide Recognized by Cytolytic T Lymphocytes on a Human Melanoma
42. Purification and NH2-terminal Amino Acid Sequence of a T-Cell-Derived Lymphokine with Growth Factor Activity for B-Cell Hybridomas
43. Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery
44. Adaptive T-cell immunity and tumor antigen recognition
45. High p16INK4a, a marker of cellular senescence, is associated with renal injury, impairment and outcome in lupus nephritis
46. DNA methylation profiling reveals a predominant immune component in breast cancers
47. Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
48. Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
49. Selective cancer-germline gene expression in pediatric brain tumors
50. Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP+ Blood Vessels in Mouse MC38 Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.